Public Health Effectiveness of the FDA 510(k) Clearance Process Balancing Patient Safety and Innovation: Workshop Report (2010) / Chapter Skim
Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 63-66
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 63... ...
Phillips, PCG, LLC Larry Kessler, University of Washington, School of Public Health (coauthor) 10:10 break 10:30 FDA's Compliance Infrastructure Timothy A
|
From page 64... ...
Bruce Burlington, Independent Consultant • William Vaughan, Consultant, Consumer's Union 3:00 break 3:15 Public Comment -- Registered Speakers 5:30 Recess Tuesday, June 15, 2010 8:30 AM Welcome David Challoner, Chair, IOM Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process 8:40 Comparative Overview of Medical Device Regulatory Systems David Jefferys, Senior Vice President, Global Regulatory, Healthcare Policy Department, Eisai Europe Ltd.
|
From page 65... ...
Feigal, Jr., David Jefferys, and Janet Trunzo 11:30 Public Comment -- Registered Speakers 12:30 PM Adjourn 1This presentation was given by Janet Trunzo on behalf of Doug Mowen, who was unexpectedly unable to attend the workshop.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.